Clinical Trial Update: Efficacy and Safety of an Ophthalmic Solution in Patients With Allergic Conjunctivitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of an ophthalmic solution in patients with allergic conjunctivitis. The results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• Unnamed ophthalmic solution

Snippet

Sponsor: Alcon Research | Conditions: Allergic Conjunctivitis | Phase 3 | Status: COMPLETED | Results posted: 2014-08-11